BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2537006)

  • 1. A rapid immunohistologic method for determining the limit of cancer invasion at the surgical margin of scirrhous carcinoma of the stomach during surgery.
    Yokota T; Takahashi T; Yamaguchi T; Sawai K
    Am J Clin Pathol; 1989 Feb; 91(2):187-90. PubMed ID: 2537006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid immunostaining method for scirrhous gastric cancer during surgery using a monoclonal antibody.
    Yokota T; Takahashi T; Yamaguchi T; Sawai K; Otsuji E; Kitamura K; Suzuyama H; Yamane T; Fujita Y
    Jpn J Surg; 1988 Mar; 18(2):232-4. PubMed ID: 2455827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative immunostaining for detection of invasive cells at the resection margin of Borrmann type 4 gastric carcinoma using monoclonal antibody S202.
    Yokota T; Yamaguchi T; Sawai K; Takahashi T
    Br J Surg; 1989 Jul; 76(7):690-2. PubMed ID: 2548652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scirrhous carcinoma cell invasion into the stomach wall detected by monoclonal antibody S202: a comparison between immunoperoxidase and hematoxylin-eosin stain.
    Yokota T; Takahashi T; Yamaguchi T; Sawai K; Hagiwara A; Shimotsuma M; Doi M; Masuko T; Hashimoto Y
    Tohoku J Exp Med; 1989 Feb; 157(2):137-44. PubMed ID: 2469136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological diagnosis of scirrhous carcinoma of the stomach using monoclonal antibody S202.
    Yokota T; Takahashi T; Yamaguchi T; Sawai K; Otsuji E; Kitamura K; Yamane T; Fujita Y
    Gastroenterol Jpn; 1988 Feb; 23(1):9-12. PubMed ID: 2832241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tumor-associated antigen in the scirrhous gastric carcinoma cell line MK-01 defined by monoclonal antibody S202.
    Yokota T; Masuko T; Yamaguchi T; Kitamura K; Takahashi T; Hashimoto Y
    Jpn J Surg; 1989 Jul; 19(4):452-8. PubMed ID: 2554042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of antigen defined by anti-scirrhous gastric carcinoma monoclonal antibody S202 in fixed human cancer tissues.
    Yokota T; Takahashi T; Yamaguchi T; Sawai K; Shimotsuma M; Doi M; Masuko T; Hashimoto Y
    Gastroenterol Jpn; 1988 Dec; 23(6):619-23. PubMed ID: 2464522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability and localization of biotin-labeled murine monoclonal antibody to human gastric cancer in normal mice and nude mice-human tumor models.
    Yokota T; Yamaguchi T; Kitamura K; Otsuji E; Sawai K; Takahashi T
    J Histochem Cytochem; 1990 Apr; 38(4):585-8. PubMed ID: 2156923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical treatment of scirrhous carcinoma of the stomach].
    Iwanaga T; Imaoka S; Furukawa H; Hiratsuka M
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2512-9. PubMed ID: 3017227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A monoclonal antibody reactive with scirrhous carcinoma of the stomach].
    Sekine T
    Gan No Rinsho; 1984 May; 30(6 Suppl):552-7. PubMed ID: 6086969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An extended operation for scirrhous gastric cancer--its significance and procedure].
    Hiratsuka M; Furukawa H; Iwanaga T; Tamura S; Yasuda T; Nakano H; Nakamori S; Ohigashi H; Kameyama M; Sasaki Y
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2392-7. PubMed ID: 7944482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2001; 48(41):1509-12. PubMed ID: 11677997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach.
    Otsuji E; Kuriu Y; Okamoto K; Ochiai T; Ichikawa D; Hagiwara A; Yamagishi H
    Am J Surg; 2004 Sep; 188(3):327-32. PubMed ID: 15450843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach.
    Yonezawa S; Kitajima S; Higashi M; Osako M; Horinouchi M; Yokoyama S; Kitamoto S; Yamada N; Tamura Y; Shimizu T; Tabata M; Goto M
    Gastric Cancer; 2012 Oct; 15(4):370-81. PubMed ID: 22237656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical results of scirrhous carcinoma of the stomach].
    Kito T; Yamamura Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1256-61. PubMed ID: 2837985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scirrhous carcinoma occurring in the corpus (body) of the stomach.
    Nagayo T; Yokoyama H
    Acta Pathol Jpn; 1974 Nov; 24(6):797-814. PubMed ID: 4376327
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of endoscopic pinch biopsy after argon plasma coagulation treatment for diagnosing scirrhous gastric carcinoma.
    Kato T; Fujisaki M; Tajiri H
    Endoscopy; 2008 Sep; 40 Suppl 2():E232. PubMed ID: 18991213
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
    Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scirrhous endocrine cell carcinoma of the stomach with synchronous production of six polypeptide hormones and glycoproteins. A case report.
    Yokozaki H; Tahara E
    Hiroshima J Med Sci; 1985 Dec; 34(4):381-5. PubMed ID: 3007399
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proliferation of scirrhous type of gastric carcinoma and its treatment].
    Kamei H; Terabe K; Yamamura Y; Kondo T
    Gan No Rinsho; 1984 May; 30(6 Suppl):749-52. PubMed ID: 6086976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.